Distal cap-assisted EMR allows the safe and effective resection of adherent dysplastic lesions in the setting of inflammatory bowel disease: a multicenter retrospective study (with video).
Gastrointest Endosc
; 2024 Jul 23.
Article
em En
| MEDLINE
| ID: mdl-39053652
ABSTRACT
BACKGROUND AND AIMS:
EMR is established as the primary approach for large and complex dysplastic lesions. However, submucosal fibrosis caused by previous attempts at removal, biopsy sampling, inflammation, or tattoo placement can cause a benign "negative lift sign" and create difficulty for EMR. Here, we present the use of distal cap-assisted EMR (EMR-DC) specifically for the use of resecting dysplastic colonic lesions when submucosal fibrosis is present in patients with inflammatory bowel disease (IBD).METHODS:
Sixteen IBD patients were retrospectively evaluated from 2 high-volume centers. Patient demographics, lesion pathology and classification, outcomes including time and success of resection, serious adverse events (SAEs) within 30 days of the procedure, and efficacy were measured.RESULTS:
Seventy-five percent of patients treated with EMR-DC achieved complete resection with no SAEs within 30 days of the procedure.CONCLUSIONS:
EMR-DC represents an attractive option for the resection of adherent, dysplastic lesions in chronic IBD that is effective, safe, and inexpensive.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article